speb/financial-data huggingface dataset:
FMR.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 568577.00
FMR.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -3757274.00
FMR.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 917.00
FMR.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 161551.00
FMR.AX income_statement (annual, 2024-06-30) — Pretax Income: -1239470.00
FMR.AX cash_flow (annual, 2024-06-30) — Purchase Of Business: 42331.00
FMR.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -1799.00
FMR.AX cash_flow (annual, 2024-06-30) — Receiptsfrom Customers: 2127590.00
FMR.AX balance_sheet (annual, 2024-06-30) — Receivables: 35444.00
FMR.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -33765.00
FMR.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -29029176.00
FMR.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 544202.00
FMR.AX cash_flow (annual, 2024-06-30) — Sale Of Business: -211144.00
FMR.AX cash_flow (annual, 2024-06-30) — Sale Of Intangibles: 62482.00
FMR.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 1183481.00
FMR.AX balance_sheet (annual, 2024-06-30) — Share Issued: 23415322.00
FMR.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 4840385.00
FMR.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 4840385.00
FMR.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
FMR.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
FMR.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
FMR.AX balance_sheet (annual, 2024-06-30) — Total Assets: 5409879.00
FMR.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 4840385.00
FMR.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 4840385.00
FMR.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 569494.00
FMR.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 927669.00
FMR.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
FMR.AX balance_sheet (annual, 2024-06-30) — Working Capital: 3912716.00
FMR.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 23521707.00
FMR.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.05
FMR.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 23521707.00
FMR.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.05
FMR.TO cash_flow (annual, 2021-07-31) — Capital Expenditure: -342343.00
FMR.TO cash_flow (annual, 2021-07-31) — Capital Expenditure Reported: -342343.00
FMR.TO cash_flow (annual, 2021-07-31) — Change In Other Current Liabilities: 0.00
FMR.TO cash_flow (annual, 2021-07-31) — Common Stock Issuance: 0.00
FMR.TO cash_flow (annual, 2021-07-31) — Effect Of Exchange Rate Changes: 0.00
FMR.TO income_statement (annual, 2021-07-31) — Interest Expense: 17055.00
FMR.TO income_statement (annual, 2021-07-31) — Interest Expense Non Operating: 17055.00
FMR.TO cash_flow (annual, 2021-07-31) — Issuance Of Capital Stock: 0.00
FMR.TO balance_sheet (annual, 2021-07-31) — Loans Receivable: 269604.00
FMR.TO cash_flow (annual, 2021-07-31) — Net Business Purchase And Sale: 0.00
FMR.TO cash_flow (annual, 2021-07-31) — Net Common Stock Issuance: 0.00
FMR.TO cash_flow (annual, 2021-07-31) — Net Other Investing Changes: -1333245.00
FMR.TO balance_sheet (annual, 2021-07-31) — Net PPE: 1120548.00
FMR.TO income_statement (annual, 2021-07-31) — Other Non Operating Income Expenses: 20861.00
FMR.TO cash_flow (annual, 2021-07-31) — Sale Of Business: 0.00
FMR.TO income_statement (annual, 2022-07-31) — +Operating Expense: 10574018.00
FMR.TO income_statement (annual, 2022-07-31) — +Total Revenue: 0.00
FMR.TO balance_sheet (annual, 2022-07-31) — Accounts Receivable: 601025.00
FMR.TO cash_flow (annual, 2022-07-31) — Asset Impairment Charge: 0.00
FMR.TO income_statement (annual, 2022-07-31) — Basic Average Shares: 9609713.00
FMR.TO income_statement (annual, 2022-07-31) — Basic EPS: -1.30
FMR.TO cash_flow (annual, 2022-07-31) — Beginning Cash Position: 201235.00
FMR.TO balance_sheet (annual, 2022-07-31) — Capital Stock: 35251842.00
FMR.TO balance_sheet (annual, 2022-07-31) — Cash And Cash Equivalents: 163161.00
FMR.TO balance_sheet (annual, 2022-07-31) — Cash Cash Equivalents And Short Term Investments: 8201554.00
FMR.TO balance_sheet (annual, 2022-07-31) — Cash Financial: 163161.00
FMR.TO cash_flow (annual, 2022-07-31) — Cash Flow From Continuing Financing Activities: 3397645.00
FMR.TO cash_flow (annual, 2022-07-31) — Cash Flow From Continuing Investing Activities: 2254938.00
FMR.TO cash_flow (annual, 2022-07-31) — Cash Flow From Continuing Operating Activities: -5690657.00
FMR.TO cash_flow (annual, 2022-07-31) — Change In Other Current Liabilities: 200000.00
FMR.TO cash_flow (annual, 2022-07-31) — Change In Payables And Accrued Expense: -2302.00
FMR.TO cash_flow (annual, 2022-07-31) — Change In Receivables: -348324.00
FMR.TO cash_flow (annual, 2022-07-31) — Change In Working Capital: -150626.00
FMR.TO cash_flow (annual, 2022-07-31) — Changes In Account Receivables: -348324.00
FMR.TO cash_flow (annual, 2022-07-31) — Changes In Cash: -38074.00
FMR.TO balance_sheet (annual, 2022-07-31) — Common Stock: 35251842.00
FMR.TO balance_sheet (annual, 2022-07-31) — Common Stock Equity: 8389391.00
FMR.TO cash_flow (annual, 2022-07-31) — Common Stock Issuance: 3450000.00
FMR.TO balance_sheet (annual, 2022-07-31) — Current Assets: 9107953.00
FMR.TO balance_sheet (annual, 2022-07-31) — Current Debt: 200000.00
FMR.TO balance_sheet (annual, 2022-07-31) — Current Debt And Capital Lease Obligation: 200000.00
FMR.TO balance_sheet (annual, 2022-07-31) — Current Liabilities: 718562.00
FMR.TO income_statement (annual, 2022-07-31) — Diluted Average Shares: 9609713.00
FMR.TO income_statement (annual, 2022-07-31) — Diluted EPS: -1.30
FMR.TO income_statement (annual, 2022-07-31) — Diluted NI Availto Com Stockholders: -12057828.00
FMR.TO income_statement (annual, 2022-07-31) — EBIT: -10574018.00
FMR.TO income_statement (annual, 2022-07-31) — EBITDA: -10574018.00
FMR.TO cash_flow (annual, 2022-07-31) — End Cash Position: 163161.00
FMR.TO cash_flow (annual, 2022-07-31) — Financing Cash Flow: 3397645.00
FMR.TO cash_flow (annual, 2022-07-31) — Free Cash Flow: -5690657.00
FMR.TO cash_flow (annual, 2022-07-31) — Gain Loss On Investment Securities: 502281.00
FMR.TO income_statement (annual, 2022-07-31) — Gain On Sale Of Security: -1528704.00
FMR.TO income_statement (annual, 2022-07-31) — General And Administrative Expense: 4980454.00
FMR.TO income_statement (annual, 2022-07-31) — Interest Income: 26398.00
FMR.TO income_statement (annual, 2022-07-31) — Interest Income Non Operating: 26398.00
FMR.TO balance_sheet (annual, 2022-07-31) — Invested Capital: 8589391.00
FMR.TO cash_flow (annual, 2022-07-31) — Investing Cash Flow: 2254938.00
FMR.TO cash_flow (annual, 2022-07-31) — Issuance Of Capital Stock: 3450000.00
FMR.TO cash_flow (annual, 2022-07-31) — Issuance Of Debt: 0.00
FMR.TO balance_sheet (annual, 2022-07-31) — Loans Receivable: 185509.00
FMR.TO cash_flow (annual, 2022-07-31) — Net Business Purchase And Sale: 4722.00
FMR.TO cash_flow (annual, 2022-07-31) — Net Common Stock Issuance: 3450000.00
FMR.TO balance_sheet (annual, 2022-07-31) — Net Debt: 36839.00
FMR.TO cash_flow (annual, 2022-07-31) — Net Foreign Currency Exchange Gain Loss: -70426.00
FMR.TO income_statement (annual, 2022-07-31) — Net Income: -12057828.00
FMR.TO income_statement (annual, 2022-07-31) — Net Income Common Stockholders: -12057828.00
FMR.TO income_statement (annual, 2022-07-31) — Net Income Continuous Operations: -12057828.00
FMR.TO income_statement (annual, 2022-07-31) — Net Income From Continuing And Discontinued Operation: -12057828.00
FMR.TO income_statement (annual, 2022-07-31) — Net Income From Continuing Operation Net Minority Interest: -12057828.00
FMR.TO cash_flow (annual, 2022-07-31) — Net Income From Continuing Operations: -12057828.00
FMR.TO income_statement (annual, 2022-07-31) — Net Income Including Noncontrolling Interests: -12057828.00
FMR.TO income_statement (annual, 2022-07-31) — Net Interest Income: 26398.00
FMR.TO cash_flow (annual, 2022-07-31) — Net Investment Purchase And Sale: 2148302.00
FMR.TO cash_flow (annual, 2022-07-31) — Net Issuance Payments Of Debt: 0.00
FMR.TO income_statement (annual, 2022-07-31) — Net Non Operating Interest Income Expense: 26398.00
FMR.TO cash_flow (annual, 2022-07-31) — Net Other Financing Charges: -52355.00
FMR.TO cash_flow (annual, 2022-07-31) — Net Other Investing Changes: 101914.00
FMR.TO cash_flow (annual, 2022-07-31) — Net Short Term Debt Issuance: 0.00
FMR.TO balance_sheet (annual, 2022-07-31) — Net Tangible Assets: 8389391.00
FMR.TO income_statement (annual, 2022-07-31) — Normalized EBITDA: -9045314.00
FMR.TO income_statement (annual, 2022-07-31) — Normalized Income: -10529124.00
FMR.TO cash_flow (annual, 2022-07-31) — Operating Cash Flow: -5690657.00
FMR.TO cash_flow (annual, 2022-07-31) — Operating Gains Losses: 431855.00
FMR.TO income_statement (annual, 2022-07-31) — Operating Income: -10574018.00
FMR.TO income_statement (annual, 2022-07-31) — Operating Revenue: 0.00
FMR.TO balance_sheet (annual, 2022-07-31) — Ordinary Shares Number: 12827597.00
FMR.TO balance_sheet (annual, 2022-07-31) — Other Current Borrowings: 200000.00
FMR.TO balance_sheet (annual, 2022-07-31) — Other Equity Interest: 2116650.00
FMR.TO income_statement (annual, 2022-07-31) — Other Gand A: 4314290.00
FMR.TO income_statement (annual, 2022-07-31) — Other Income Expense: -1510208.00
FMR.TO cash_flow (annual, 2022-07-31) — Other Non Cash Items: 4559509.00
FMR.TO income_statement (annual, 2022-07-31) — Other Non Operating Income Expenses: 18496.00
FMR.TO income_statement (annual, 2022-07-31) — Other Operating Expenses: 5593564.00
FMR.TO balance_sheet (annual, 2022-07-31) — Other Short Term Investments: 8038393.00
FMR.TO balance_sheet (annual, 2022-07-31) — Payables And Accrued Expenses: 518562.00
FMR.TO balance_sheet (annual, 2022-07-31) — Prepaid Assets: 119865.00
FMR.TO income_statement (annual, 2022-07-31) — Pretax Income: -12057828.00
FMR.TO cash_flow (annual, 2022-07-31) — Purchase Of Investment: -751140.00
FMR.TO balance_sheet (annual, 2022-07-31) — Receivables: 786534.00
FMR.TO balance_sheet (annual, 2022-07-31) — Retained Earnings: -28979101.00
FMR.TO income_statement (annual, 2022-07-31) — Salaries And Wages: 666164.00
FMR.TO cash_flow (annual, 2022-07-31) — Sale Of Business: 4722.00
FMR.TO cash_flow (annual, 2022-07-31) — Sale Of Investment: 2899442.00
FMR.TO income_statement (annual, 2022-07-31) — Selling General And Administration: 4980454.00
FMR.TO balance_sheet (annual, 2022-07-31) — Share Issued: 12827597.00
FMR.TO cash_flow (annual, 2022-07-31) — Short Term Debt Issuance: 0.00
FMR.TO income_statement (annual, 2022-07-31) — Special Income Charges: 0.00
FMR.TO cash_flow (annual, 2022-07-31) — Stock Based Compensation: 435990.00
FMR.TO balance_sheet (annual, 2022-07-31) — Stockholders Equity: 8389391.00
FMR.TO balance_sheet (annual, 2022-07-31) — Tangible Book Value: 8389391.00
FMR.TO income_statement (annual, 2022-07-31) — Tax Effect Of Unusual Items: 0.00
FMR.TO income_statement (annual, 2022-07-31) — Tax Rate For Calcs: 0.00
FMR.TO balance_sheet (annual, 2022-07-31) — Total Assets: 9107953.00
FMR.TO balance_sheet (annual, 2022-07-31) — Total Capitalization: 8389391.00
FMR.TO balance_sheet (annual, 2022-07-31) — Total Debt: 200000.00
FMR.TO balance_sheet (annual, 2022-07-31) — Total Equity Gross Minority Interest: 8389391.00
FMR.TO income_statement (annual, 2022-07-31) — Total Expenses: 10574018.00
FMR.TO balance_sheet (annual, 2022-07-31) — Total Liabilities Net Minority Interest: 718562.00
FMR.TO balance_sheet (annual, 2022-07-31) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (annual, 2022-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
FMR.TO income_statement (annual, 2022-07-31) — Total Unusual Items: -1528704.00
FMR.TO income_statement (annual, 2022-07-31) — Total Unusual Items Excluding Goodwill: -1528704.00
FMR.TO cash_flow (annual, 2022-07-31) — Unrealized Gain Loss On Investment Securities: 1090443.00
FMR.TO balance_sheet (annual, 2022-07-31) — Working Capital: 8389391.00
FMR.TO income_statement (annual, 2022-07-31) — Write Off: 0.00
FMR.TO income_statement (annual, 2023-07-31) — +Operating Expense: 1937592.00
FMR.TO income_statement (annual, 2023-07-31) — +Total Revenue: 0.00
FMR.TO balance_sheet (annual, 2023-07-31) — Accounts Receivable: 23929.00
FMR.TO cash_flow (annual, 2023-07-31) — Asset Impairment Charge: 209590.00
FMR.TO income_statement (annual, 2023-07-31) — Basic Average Shares: 12827597.00
FMR.TO income_statement (annual, 2023-07-31) — Basic EPS: -0.40
FMR.TO cash_flow (annual, 2023-07-31) — Beginning Cash Position: 163161.00
FMR.TO balance_sheet (annual, 2023-07-31) — Capital Stock: 35251842.00
FMR.TO balance_sheet (annual, 2023-07-31) — Cash And Cash Equivalents: 35084.00
FMR.TO balance_sheet (annual, 2023-07-31) — Cash Cash Equivalents And Short Term Investments: 3354447.00
FMR.TO balance_sheet (annual, 2023-07-31) — Cash Financial: 35084.00
FMR.TO cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Financing Activities: 90000.00
FMR.TO cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Investing Activities: 1162301.00
FMR.TO cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Operating Activities: -1380378.00
FMR.TO cash_flow (annual, 2023-07-31) — Change In Other Current Liabilities: -200000.00
FMR.TO cash_flow (annual, 2023-07-31) — Change In Payables And Accrued Expense: 156724.00
FMR.TO cash_flow (annual, 2023-07-31) — Change In Receivables: 604507.00
FMR.TO cash_flow (annual, 2023-07-31) — Change In Working Capital: 561231.00
FMR.TO cash_flow (annual, 2023-07-31) — Changes In Account Receivables: 604507.00
FMR.TO cash_flow (annual, 2023-07-31) — Changes In Cash: -128077.00
FMR.TO balance_sheet (annual, 2023-07-31) — Common Stock: 35251842.00
FMR.TO balance_sheet (annual, 2023-07-31) — Common Stock Equity: 2707069.00
FMR.TO cash_flow (annual, 2023-07-31) — Common Stock Issuance: 0.00
FMR.TO balance_sheet (annual, 2023-07-31) — Current Assets: 3471330.00
FMR.TO balance_sheet (annual, 2023-07-31) — Current Debt: 90976.00
FMR.TO balance_sheet (annual, 2023-07-31) — Current Debt And Capital Lease Obligation: 90976.00
FMR.TO balance_sheet (annual, 2023-07-31) — Current Liabilities: 764261.00
FMR.TO income_statement (annual, 2023-07-31) — Diluted Average Shares: 12827597.00
FMR.TO income_statement (annual, 2023-07-31) — Diluted EPS: -0.40
FMR.TO income_statement (annual, 2023-07-31) — Diluted NI Availto Com Stockholders: -5682322.00
FMR.TO income_statement (annual, 2023-07-31) — EBIT: -5681346.00
FMR.TO income_statement (annual, 2023-07-31) — EBITDA: -5681346.00
FMR.TO cash_flow (annual, 2023-07-31) — End Cash Position: 35084.00
FMR.TO cash_flow (annual, 2023-07-31) — Financing Cash Flow: 90000.00
FMR.TO cash_flow (annual, 2023-07-31) — Free Cash Flow: -1380378.00
FMR.TO cash_flow (annual, 2023-07-31) — Gain Loss On Investment Securities: 1528271.00
FMR.TO cash_flow (annual, 2023-07-31) — Gain Loss On Sale Of Business: 0.00
FMR.TO cash_flow (annual, 2023-07-31) — Gain Loss On Sale Of PPE: 0.00
FMR.TO income_statement (annual, 2023-07-31) — Gain On Sale Of Business: 0.00
FMR.TO income_statement (annual, 2023-07-31) — Gain On Sale Of Ppe: 0.00
FMR.TO income_statement (annual, 2023-07-31) — Gain On Sale Of Security: -3554345.00
FMR.TO income_statement (annual, 2023-07-31) — General And Administrative Expense: 1642935.00
FMR.TO income_statement (annual, 2023-07-31) — Interest Expense: 976.00
FMR.TO income_statement (annual, 2023-07-31) — Interest Expense Non Operating: 976.00
FMR.TO income_statement (annual, 2023-07-31) — Interest Income: 20181.00
FMR.TO income_statement (annual, 2023-07-31) — Interest Income Non Operating: 20181.00
FMR.TO cash_flow (annual, 2023-07-31) — Interest Received Cfi: 976.00
FMR.TO balance_sheet (annual, 2023-07-31) — Invested Capital: 2798045.00
FMR.TO cash_flow (annual, 2023-07-31) — Investing Cash Flow: 1162301.00
FMR.TO cash_flow (annual, 2023-07-31) — Issuance Of Capital Stock: 0.00
FMR.TO cash_flow (annual, 2023-07-31) — Issuance Of Debt: 90000.00
FMR.TO balance_sheet (annual, 2023-07-31) — Loans Receivable: 0.00
FMR.TO income_statement (annual, 2023-07-31) — Minority Interests: 0.00
FMR.TO cash_flow (annual, 2023-07-31) — Net Business Purchase And Sale: 0.00
FMR.TO cash_flow (annual, 2023-07-31) — Net Common Stock Issuance: 0.00
FMR.TO balance_sheet (annual, 2023-07-31) — Net Debt: 55892.00
FMR.TO cash_flow (annual, 2023-07-31) — Net Foreign Currency Exchange Gain Loss: -61651.00
FMR.TO income_statement (annual, 2023-07-31) — Net Income: -5682322.00
FMR.TO income_statement (annual, 2023-07-31) — Net Income Common Stockholders: -5682322.00
FMR.TO income_statement (annual, 2023-07-31) — Net Income Continuous Operations: -5682322.00
FMR.TO income_statement (annual, 2023-07-31) — Net Income From Continuing And Discontinued Operation: -5682322.00
FMR.TO income_statement (annual, 2023-07-31) — Net Income From Continuing Operation Net Minority Interest: -5682322.00
FMR.TO cash_flow (annual, 2023-07-31) — Net Income From Continuing Operations: -5682322.00
FMR.TO income_statement (annual, 2023-07-31) — Net Income Including Noncontrolling Interests: -5682322.00
FMR.TO income_statement (annual, 2023-07-31) — Net Interest Income: 19205.00
FMR.TO cash_flow (annual, 2023-07-31) — Net Investment Purchase And Sale: 1161325.00
FMR.TO cash_flow (annual, 2023-07-31) — Net Issuance Payments Of Debt: 90000.00
FMR.TO income_statement (annual, 2023-07-31) — Net Non Operating Interest Income Expense: 19205.00
FMR.TO cash_flow (annual, 2023-07-31) — Net Other Investing Changes: 976.00
FMR.TO cash_flow (annual, 2023-07-31) — Net Short Term Debt Issuance: 90000.00
FMR.TO balance_sheet (annual, 2023-07-31) — Net Tangible Assets: 2707069.00
FMR.TO income_statement (annual, 2023-07-31) — Normalized EBITDA: -1917411.00
FMR.TO income_statement (annual, 2023-07-31) — Normalized Income: -1918387.00
FMR.TO cash_flow (annual, 2023-07-31) — Operating Cash Flow: -1380378.00
FMR.TO cash_flow (annual, 2023-07-31) — Operating Gains Losses: 1466620.00
FMR.TO income_statement (annual, 2023-07-31) — Operating Income: -1937592.00
FMR.TO income_statement (annual, 2023-07-31) — Operating Revenue: 0.00
FMR.TO balance_sheet (annual, 2023-07-31) — Ordinary Shares Number: 12827597.00
FMR.TO balance_sheet (annual, 2023-07-31) — Other Current Borrowings: 90976.00
FMR.TO balance_sheet (annual, 2023-07-31) — Other Equity Interest: 1986005.00
FMR.TO income_statement (annual, 2023-07-31) — Other Gand A: 1601894.00
FMR.TO income_statement (annual, 2023-07-31) — Other Income Expense: -3763935.00
FMR.TO cash_flow (annual, 2023-07-31) — Other Non Cash Items: -18975.00
FMR.TO income_statement (annual, 2023-07-31) — Other Operating Expenses: 294657.00
FMR.TO balance_sheet (annual, 2023-07-31) — Other Short Term Investments: 3319363.00
FMR.TO balance_sheet (annual, 2023-07-31) — Payables And Accrued Expenses: 673285.00
FMR.TO balance_sheet (annual, 2023-07-31) — Prepaid Assets: 92954.00
FMR.TO income_statement (annual, 2023-07-31) — Pretax Income: -5682322.00
FMR.TO cash_flow (annual, 2023-07-31) — Purchase Of Investment: -305000.00
FMR.TO balance_sheet (annual, 2023-07-31) — Receivables: 23929.00
FMR.TO balance_sheet (annual, 2023-07-31) — Retained Earnings: -34530778.00
FMR.TO income_statement (annual, 2023-07-31) — Salaries And Wages: 41041.00
FMR.TO cash_flow (annual, 2023-07-31) — Sale Of Business: 0.00
FMR.TO cash_flow (annual, 2023-07-31) — Sale Of Investment: 1466325.00
FMR.TO income_statement (annual, 2023-07-31) — Selling General And Administration: 1642935.00
FMR.TO balance_sheet (annual, 2023-07-31) — Share Issued: 12827597.00
FMR.TO cash_flow (annual, 2023-07-31) — Short Term Debt Issuance: 90000.00
FMR.TO income_statement (annual, 2023-07-31) — Special Income Charges: -209590.00
FMR.TO cash_flow (annual, 2023-07-31) — Stock Based Compensation: -1002.00
FMR.TO balance_sheet (annual, 2023-07-31) — Stockholders Equity: 2707069.00
FMR.TO balance_sheet (annual, 2023-07-31) — Tangible Book Value: 2707069.00
FMR.TO income_statement (annual, 2023-07-31) — Tax Effect Of Unusual Items: 0.00
FMR.TO income_statement (annual, 2023-07-31) — Tax Rate For Calcs: 0.00
FMR.TO balance_sheet (annual, 2023-07-31) — Total Assets: 3471330.00
FMR.TO balance_sheet (annual, 2023-07-31) — Total Capitalization: 2707069.00
FMR.TO balance_sheet (annual, 2023-07-31) — Total Debt: 90976.00
FMR.TO balance_sheet (annual, 2023-07-31) — Total Equity Gross Minority Interest: 2707069.00
FMR.TO income_statement (annual, 2023-07-31) — Total Expenses: 1937592.00
FMR.TO balance_sheet (annual, 2023-07-31) — Total Liabilities Net Minority Interest: 764261.00
FMR.TO balance_sheet (annual, 2023-07-31) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (annual, 2023-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
FMR.TO income_statement (annual, 2023-07-31) — Total Unusual Items: -3763935.00
FMR.TO income_statement (annual, 2023-07-31) — Total Unusual Items Excluding Goodwill: -3763935.00
FMR.TO cash_flow (annual, 2023-07-31) — Unrealized Gain Loss On Investment Securities: 2084480.00
FMR.TO balance_sheet (annual, 2023-07-31) — Working Capital: 2707069.00
FMR.TO income_statement (annual, 2023-07-31) — Write Off: 209590.00
FMR.TO income_statement (annual, 2024-07-31) — +Operating Expense: 2104357.00
FMR.TO income_statement (annual, 2024-07-31) — +Total Revenue: 0.00
FMR.TO balance_sheet (annual, 2024-07-31) — Accounts Receivable: 287844.00
FMR.TO cash_flow (annual, 2024-07-31) — Asset Impairment Charge: 353408.00
FMR.TO income_statement (annual, 2024-07-31) — Basic Average Shares: 12907461.00
FMR.TO income_statement (annual, 2024-07-31) — Basic EPS: -0.21
FMR.TO cash_flow (annual, 2024-07-31) — Beginning Cash Position: 35084.00
FMR.TO balance_sheet (annual, 2024-07-31) — Capital Stock: 35332342.00
FMR.TO balance_sheet (annual, 2024-07-31) — Cash And Cash Equivalents: 55661.00
FMR.TO balance_sheet (annual, 2024-07-31) — Cash Cash Equivalents And Short Term Investments: 2043926.00
FMR.TO balance_sheet (annual, 2024-07-31) — Cash Financial: 55661.00
FMR.TO cash_flow (annual, 2024-07-31) — Cash Flow From Continuing Financing Activities: 43000.00
FMR.TO cash_flow (annual, 2024-07-31) — Cash Flow From Continuing Investing Activities: 471308.00
FMR.TO cash_flow (annual, 2024-07-31) — Cash Flow From Continuing Operating Activities: -493731.00
FMR.TO cash_flow (annual, 2024-07-31) — Change In Other Current Liabilities: 0.00
FMR.TO cash_flow (annual, 2024-07-31) — Change In Payables And Accrued Expense: 1257605.00
FMR.TO cash_flow (annual, 2024-07-31) — Change In Receivables: -13122.00
FMR.TO cash_flow (annual, 2024-07-31) — Change In Working Capital: 1244483.00
FMR.TO cash_flow (annual, 2024-07-31) — Changes In Account Receivables: -13122.00
FMR.TO cash_flow (annual, 2024-07-31) — Changes In Cash: 20577.00
FMR.TO balance_sheet (annual, 2024-07-31) — Common Stock: 35332342.00
FMR.TO balance_sheet (annual, 2024-07-31) — Common Stock Equity: 314927.00
FMR.TO balance_sheet (annual, 2024-07-31) — Current Assets: 2393043.00
FMR.TO balance_sheet (annual, 2024-07-31) — Current Debt: 148976.00
FMR.TO balance_sheet (annual, 2024-07-31) — Current Debt And Capital Lease Obligation: 148976.00
FMR.TO balance_sheet (annual, 2024-07-31) — Current Liabilities: 2078116.00
FMR.TO income_statement (annual, 2024-07-31) — Diluted Average Shares: 12907461.00
FMR.TO income_statement (annual, 2024-07-31) — Diluted EPS: -0.21
FMR.TO income_statement (annual, 2024-07-31) — Diluted NI Availto Com Stockholders: -2609082.00
FMR.TO income_statement (annual, 2024-07-31) — EBIT: -2711475.00
FMR.TO income_statement (annual, 2024-07-31) — EBITDA: -2711475.00
FMR.TO cash_flow (annual, 2024-07-31) — End Cash Position: 55661.00
FMR.TO cash_flow (annual, 2024-07-31) — Financing Cash Flow: 43000.00
FMR.TO cash_flow (annual, 2024-07-31) — Free Cash Flow: -493731.00
FMR.TO cash_flow (annual, 2024-07-31) — Gain Loss On Investment Securities: 338313.00
FMR.TO cash_flow (annual, 2024-07-31) — Gain Loss On Sale Of Business: 34801.00
FMR.TO cash_flow (annual, 2024-07-31) — Gain Loss On Sale Of PPE: -503915.00
FMR.TO income_statement (annual, 2024-07-31) — Gain On Sale Of Business: -34801.00
FMR.TO income_statement (annual, 2024-07-31) — Gain On Sale Of Ppe: 503915.00
FMR.TO income_statement (annual, 2024-07-31) — Gain On Sale Of Security: -766139.00
FMR.TO income_statement (annual, 2024-07-31) — General And Administrative Expense: 1518840.00
FMR.TO income_statement (annual, 2024-07-31) — Interest Expense: 15037.00
FMR.TO income_statement (annual, 2024-07-31) — Interest Expense Non Operating: 15037.00
FMR.TO income_statement (annual, 2024-07-31) — Interest Income: 3971.00
FMR.TO income_statement (annual, 2024-07-31) — Interest Income Non Operating: 3971.00
FMR.TO cash_flow (annual, 2024-07-31) — Interest Received Cfi: 0.00
FMR.TO balance_sheet (annual, 2024-07-31) — Invested Capital: 463903.00
FMR.TO cash_flow (annual, 2024-07-31) — Investing Cash Flow: 471308.00
FMR.TO cash_flow (annual, 2024-07-31) — Issuance Of Debt: 43000.00
FMR.TO income_statement (annual, 2024-07-31) — Minority Interests: 117430.00
FMR.TO balance_sheet (annual, 2024-07-31) — Net Debt: 93315.00
FMR.TO cash_flow (annual, 2024-07-31) — Net Foreign Currency Exchange Gain Loss: -101236.00
FMR.TO income_statement (annual, 2024-07-31) — Net Income: -2609082.00
FMR.TO income_statement (annual, 2024-07-31) — Net Income Common Stockholders: -2609082.00
FMR.TO income_statement (annual, 2024-07-31) — Net Income Continuous Operations: -2726512.00
FMR.TO income_statement (annual, 2024-07-31) — Net Income From Continuing And Discontinued Operation: -2609082.00
FMR.TO income_statement (annual, 2024-07-31) — Net Income From Continuing Operation Net Minority Interest: -2609082.00
FMR.TO cash_flow (annual, 2024-07-31) — Net Income From Continuing Operations: -2609082.00
FMR.TO income_statement (annual, 2024-07-31) — Net Income Including Noncontrolling Interests: -2726512.00
FMR.TO income_statement (annual, 2024-07-31) — Net Interest Income: -11066.00
FMR.TO cash_flow (annual, 2024-07-31) — Net Investment Purchase And Sale: 270765.00
FMR.TO cash_flow (annual, 2024-07-31) — Net Issuance Payments Of Debt: 43000.00
FMR.TO income_statement (annual, 2024-07-31) — Net Non Operating Interest Income Expense: -11066.00
FMR.TO cash_flow (annual, 2024-07-31) — Net Other Investing Changes: 200543.00
FMR.TO cash_flow (annual, 2024-07-31) — Net Short Term Debt Issuance: 43000.00
FMR.TO balance_sheet (annual, 2024-07-31) — Net Tangible Assets: 314927.00
FMR.TO income_statement (annual, 2024-07-31) — Normalized EBITDA: -2061042.00
FMR.TO income_statement (annual, 2024-07-31) — Normalized Income: -1958649.00
FMR.TO cash_flow (annual, 2024-07-31) — Operating Cash Flow: -493731.00
FMR.TO cash_flow (annual, 2024-07-31) — Operating Gains Losses: -232037.00
FMR.TO income_statement (annual, 2024-07-31) — Operating Income: -2104357.00
FMR.TO income_statement (annual, 2024-07-31) — Operating Revenue: 0.00
FMR.TO balance_sheet (annual, 2024-07-31) — Ordinary Shares Number: 13057597.00
FMR.TO balance_sheet (annual, 2024-07-31) — Other Current Borrowings: 148976.00
FMR.TO balance_sheet (annual, 2024-07-31) — Other Equity Interest: 2032415.00
FMR.TO income_statement (annual, 2024-07-31) — Other Gand A: 1302218.00
FMR.TO income_statement (annual, 2024-07-31) — Other Income Expense: -611089.00
FMR.TO cash_flow (annual, 2024-07-31) — Other Non Cash Items: 11049.00
FMR.TO income_statement (annual, 2024-07-31) — Other Non Operating Income Expenses: 39344.00
FMR.TO income_statement (annual, 2024-07-31) — Other Operating Expenses: 585517.00
FMR.TO balance_sheet (annual, 2024-07-31) — Other Short Term Investments: 1988265.00
FMR.TO balance_sheet (annual, 2024-07-31) — Payables And Accrued Expenses: 1929140.00
FMR.TO balance_sheet (annual, 2024-07-31) — Prepaid Assets: 61273.00
FMR.TO income_statement (annual, 2024-07-31) — Pretax Income: -2726512.00
FMR.TO cash_flow (annual, 2024-07-31) — Purchase Of Investment: 0.00
FMR.TO balance_sheet (annual, 2024-07-31) — Receivables: 287844.00
FMR.TO cash_flow (annual, 2024-07-31) — Repayment Of Debt: 0.00
FMR.TO balance_sheet (annual, 2024-07-31) — Retained Earnings: -37049830.00
FMR.TO income_statement (annual, 2024-07-31) — Salaries And Wages: 216622.00
FMR.TO cash_flow (annual, 2024-07-31) — Sale Of Investment: 270765.00
FMR.TO income_statement (annual, 2024-07-31) — Selling General And Administration: 1518840.00
FMR.TO balance_sheet (annual, 2024-07-31) — Share Issued: 13057597.00
FMR.TO cash_flow (annual, 2024-07-31) — Short Term Debt Issuance: 43000.00
FMR.TO cash_flow (annual, 2024-07-31) — Short Term Debt Payments: 0.00
FMR.TO income_statement (annual, 2024-07-31) — Special Income Charges: 115706.00
FMR.TO cash_flow (annual, 2024-07-31) — Stock Based Compensation: 215191.00
FMR.TO balance_sheet (annual, 2024-07-31) — Stockholders Equity: 314927.00
FMR.TO balance_sheet (annual, 2024-07-31) — Tangible Book Value: 314927.00
FMR.TO income_statement (annual, 2024-07-31) — Tax Effect Of Unusual Items: 0.00
FMR.TO income_statement (annual, 2024-07-31) — Tax Rate For Calcs: 0.00
FMR.TO balance_sheet (annual, 2024-07-31) — Total Assets: 2393043.00
FMR.TO balance_sheet (annual, 2024-07-31) — Total Capitalization: 314927.00
FMR.TO balance_sheet (annual, 2024-07-31) — Total Debt: 148976.00
FMR.TO balance_sheet (annual, 2024-07-31) — Total Equity Gross Minority Interest: 314927.00
FMR.TO income_statement (annual, 2024-07-31) — Total Expenses: 2104357.00
FMR.TO balance_sheet (annual, 2024-07-31) — Total Liabilities Net Minority Interest: 2078116.00
FMR.TO balance_sheet (annual, 2024-07-31) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (annual, 2024-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
FMR.TO income_statement (annual, 2024-07-31) — Total Unusual Items: -650433.00
FMR.TO income_statement (annual, 2024-07-31) — Total Unusual Items Excluding Goodwill: -650433.00
FMR.TO cash_flow (annual, 2024-07-31) — Unrealized Gain Loss On Investment Securities: 523257.00
FMR.TO balance_sheet (annual, 2024-07-31) — Working Capital: 314927.00
FMR.TO income_statement (annual, 2024-07-31) — Write Off: 353408.00
FMR.TO income_statement (quarterly, 2024-10-31) — Basic Average Shares: 13057598.00
FMR.TO income_statement (quarterly, 2024-10-31) — Basic EPS: 0.05
FMR.TO balance_sheet (quarterly, 2024-10-31) — Current Debt: 152999.00
FMR.TO balance_sheet (quarterly, 2024-10-31) — Current Debt And Capital Lease Obligation: 152999.00
FMR.TO income_statement (quarterly, 2024-10-31) — Diluted Average Shares: 13057598.00
FMR.TO income_statement (quarterly, 2024-10-31) — Diluted EPS: 0.05
FMR.TO income_statement (quarterly, 2024-10-31) — Interest Income: 0.00
FMR.TO income_statement (quarterly, 2024-10-31) — Interest Income Non Operating: 0.00
FMR.TO cash_flow (quarterly, 2024-10-31) — Long Term Debt Issuance: 47000.00
FMR.TO cash_flow (quarterly, 2024-10-31) — Long Term Debt Payments: -47197.00
FMR.TO cash_flow (quarterly, 2024-10-31) — Net Long Term Debt Issuance: -197.00
FMR.TO cash_flow (quarterly, 2024-10-31) — Net Short Term Debt Issuance: -197.00
FMR.TO balance_sheet (quarterly, 2024-10-31) — Other Current Borrowings: 152999.00
FMR.TO cash_flow (quarterly, 2024-10-31) — Short Term Debt Issuance: 47000.00
FMR.TO cash_flow (quarterly, 2024-10-31) — Short Term Debt Payments: -47197.00
FMR.TO income_statement (quarterly, 2025-01-31) — +Operating Expense: 324113.00
FMR.TO income_statement (quarterly, 2025-01-31) — +Total Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Accounts Receivable: 121234.00
FMR.TO income_statement (quarterly, 2025-01-31) — Basic Average Shares: 13057598.00
FMR.TO income_statement (quarterly, 2025-01-31) — Basic EPS: -0.16
FMR.TO cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 6283.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Capital Stock: 35332342.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 40959.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 1234322.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Cash Financial: 40959.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: 0.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: 29922.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: 4754.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: 328174.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Change In Receivables: 7839.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Change In Working Capital: 336013.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Changes In Account Receivables: 7839.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Changes In Cash: 34676.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Common Stock: 35332342.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: -1135031.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Current Assets: 1386869.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Current Debt: 157022.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Current Debt And Capital Lease Obligation: 157022.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 2521900.00
FMR.TO income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 13057598.00
FMR.TO income_statement (quarterly, 2025-01-31) — Diluted EPS: -0.16
FMR.TO income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: -2099431.00
FMR.TO income_statement (quarterly, 2025-01-31) — EBIT: -2095408.00
FMR.TO income_statement (quarterly, 2025-01-31) — EBITDA: -2095408.00
FMR.TO cash_flow (quarterly, 2025-01-31) — End Cash Position: 40959.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: 0.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Free Cash Flow: 4754.00
FMR.TO income_statement (quarterly, 2025-01-31) — Gain On Sale Of Security: -1771295.00
FMR.TO income_statement (quarterly, 2025-01-31) — General And Administrative Expense: 310236.00
FMR.TO income_statement (quarterly, 2025-01-31) — Interest Expense: 4023.00
FMR.TO income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 4023.00
FMR.TO income_statement (quarterly, 2025-01-31) — Interest Income: 0.00
FMR.TO income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 0.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Invested Capital: -978009.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: 29922.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Issuance Of Debt: 0.00
FMR.TO income_statement (quarterly, 2025-01-31) — Minority Interests: 0.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Net Debt: 116063.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Net Foreign Currency Exchange Gain Loss: 0.00
FMR.TO income_statement (quarterly, 2025-01-31) — Net Income: -2099431.00
FMR.TO income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: -2099431.00
FMR.TO income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: -2099431.00
FMR.TO income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -2099431.00
FMR.TO income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -2099431.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: -2101686.00
FMR.TO income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: -2099431.00
FMR.TO income_statement (quarterly, 2025-01-31) — Net Interest Income: -4023.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Net Investment Purchase And Sale: 29922.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: 0.00
FMR.TO income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: -4023.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Net Short Term Debt Issuance: 0.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: -1135031.00
FMR.TO income_statement (quarterly, 2025-01-31) — Normalized EBITDA: -324113.00
FMR.TO income_statement (quarterly, 2025-01-31) — Normalized Income: -328136.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: 4754.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: 12206.00
FMR.TO income_statement (quarterly, 2025-01-31) — Operating Income: -324113.00
FMR.TO income_statement (quarterly, 2025-01-31) — Operating Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 13057597.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Other Current Borrowings: 157022.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Other Equity Interest: 1990615.00
FMR.TO income_statement (quarterly, 2025-01-31) — Other Gand A: 310485.00
FMR.TO income_statement (quarterly, 2025-01-31) — Other Income Expense: -1771295.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 4023.00
FMR.TO income_statement (quarterly, 2025-01-31) — Other Operating Expenses: 13877.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Other Short Term Investments: 1193363.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 2364878.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Prepaid Assets: 31313.00
FMR.TO income_statement (quarterly, 2025-01-31) — Pretax Income: -2099431.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Receivables: 121234.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: 0.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Retained Earnings: -38457988.00
FMR.TO income_statement (quarterly, 2025-01-31) — Salaries And Wages: -249.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Sale Of Investment: 29922.00
FMR.TO income_statement (quarterly, 2025-01-31) — Selling General And Administration: 310236.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Share Issued: 13057597.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Short Term Debt Issuance: 0.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Short Term Debt Payments: 0.00
FMR.TO income_statement (quarterly, 2025-01-31) — Special Income Charges: 0.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: -249.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: -1135031.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: -1135031.00
FMR.TO income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
FMR.TO income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Total Assets: 1386869.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Total Capitalization: -1135031.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Total Debt: 157022.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: -1135031.00
FMR.TO income_statement (quarterly, 2025-01-31) — Total Expenses: 324113.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 2521900.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 0.00
FMR.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items: -1771295.00
FMR.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -1771295.00
FMR.TO cash_flow (quarterly, 2025-01-31) — Unrealized Gain Loss On Investment Securities: 1754447.00
FMR.TO balance_sheet (quarterly, 2025-01-31) — Working Capital: -1135031.00
FMR.TO income_statement (quarterly, 2025-04-30) — +Operating Expense: 335296.00
FMR.TO income_statement (quarterly, 2025-04-30) — +Total Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 126117.00
FMR.TO income_statement (quarterly, 2025-04-30) — Basic Average Shares: 13057598.00
FMR.TO income_statement (quarterly, 2025-04-30) — Basic EPS: -0.02
FMR.TO cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 40959.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Capital Stock: 35332342.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 33502.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 1276076.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Cash Financial: 33502.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: 0.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: 65400.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: -72857.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 190593.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Change In Receivables: 27000.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 217593.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: 27000.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Changes In Cash: -7457.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Common Stock: 35332342.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: -1300635.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Current Assets: 1415999.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Current Debt: 160914.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 160914.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 2716634.00
FMR.TO income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 13057598.00
FMR.TO income_statement (quarterly, 2025-04-30) — Diluted EPS: -0.02
FMR.TO income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -203069.00
FMR.TO income_statement (quarterly, 2025-04-30) — EBIT: -199177.00
FMR.TO income_statement (quarterly, 2025-04-30) — EBITDA: -199177.00
FMR.TO cash_flow (quarterly, 2025-04-30) — End Cash Position: 33502.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: 0.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Free Cash Flow: -72857.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Gain Loss On Investment Securities: 45145.00
FMR.TO income_statement (quarterly, 2025-04-30) — Gain On Sale Of Ppe: 14376.00
FMR.TO income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: 121740.00
FMR.TO income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 336030.00
FMR.TO income_statement (quarterly, 2025-04-30) — Interest Expense: 3892.00
FMR.TO income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 3892.00
FMR.TO income_statement (quarterly, 2025-04-30) — Interest Income: 3.00
FMR.TO income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 3.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Invested Capital: -1139721.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: 65400.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Issuance Of Debt: 0.00
FMR.TO income_statement (quarterly, 2025-04-30) — Minority Interests: 0.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Net Debt: 127412.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Net Foreign Currency Exchange Gain Loss: 0.00
FMR.TO income_statement (quarterly, 2025-04-30) — Net Income: -203069.00
FMR.TO income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -203069.00
FMR.TO income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: -203069.00
FMR.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -203069.00
FMR.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -203069.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: -203069.00
FMR.TO income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: -203069.00
FMR.TO income_statement (quarterly, 2025-04-30) — Net Interest Income: -3889.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: 65400.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: 0.00
FMR.TO income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -3889.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Net Short Term Debt Issuance: 0.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: -1300635.00
FMR.TO income_statement (quarterly, 2025-04-30) — Normalized EBITDA: -335293.00
FMR.TO income_statement (quarterly, 2025-04-30) — Normalized Income: -339185.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: -72857.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: 30769.00
FMR.TO income_statement (quarterly, 2025-04-30) — Operating Income: -335296.00
FMR.TO income_statement (quarterly, 2025-04-30) — Operating Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 13057597.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Other Current Borrowings: 160914.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Other Equity Interest: 2028080.00
FMR.TO income_statement (quarterly, 2025-04-30) — Other Gand A: 298316.00
FMR.TO income_statement (quarterly, 2025-04-30) — Other Income Expense: 136116.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 3892.00
FMR.TO income_statement (quarterly, 2025-04-30) — Other Operating Expenses: -734.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Other Short Term Investments: 1242574.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 2555720.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Prepaid Assets: 13806.00
FMR.TO income_statement (quarterly, 2025-04-30) — Pretax Income: -203069.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Purchase Of Investment: 0.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Receivables: 126117.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: 0.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Retained Earnings: -38661057.00
FMR.TO income_statement (quarterly, 2025-04-30) — Salaries And Wages: 37714.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 65400.00
FMR.TO income_statement (quarterly, 2025-04-30) — Selling General And Administration: 336030.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Share Issued: 13057597.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Short Term Debt Issuance: 0.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Short Term Debt Payments: 0.00
FMR.TO income_statement (quarterly, 2025-04-30) — Special Income Charges: 14376.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 37714.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: -1300635.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: -1300635.00
FMR.TO income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 0.00
FMR.TO income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Total Assets: 1415999.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Total Capitalization: -1300635.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Total Debt: 160914.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: -1300635.00
FMR.TO income_statement (quarterly, 2025-04-30) — Total Expenses: 335296.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 2716634.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 0.00
FMR.TO income_statement (quarterly, 2025-04-30) — Total Unusual Items: 136116.00
FMR.TO income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: 136116.00
FMR.TO cash_flow (quarterly, 2025-04-30) — Unrealized Gain Loss On Investment Securities: -159756.00
FMR.TO balance_sheet (quarterly, 2025-04-30) — Working Capital: -1300635.00
FMR.TO income_statement (quarterly, 2025-04-30) — Write Off: 0.00
FMR.TO income_statement (annual, 2025-07-31) — +Operating Expense: 1432946.00
FMR.TO income_statement (quarterly, 2025-07-31) — +Operating Expense: 425421.00
FMR.TO income_statement (annual, 2025-07-31) — +Total Revenue: 0.00
FMR.TO income_statement (quarterly, 2025-07-31) — +Total Revenue: 0.00
FMR.TO balance_sheet (annual, 2025-07-31) — Accounts Receivable: 47342.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 47342.00